EGF 103009, a phase II trial of lapatinib monotherapy in patients with relapsed/refractory inflammatory breast cancer (IBC) : clinical activity and biologic predictors of response
収録刊行物
-
- Proc Am Soc Clin Oncol.
-
Proc Am Soc Clin Oncol. 2006
- Tweet
詳細情報
-
- CRID
- 1572543025455268736
-
- NII論文ID
- 10021288445
-
- データソース種別
-
- CiNii Articles